Description
Ipamorelin is investigated as a peptide-based research tool for examining selective ghrelin receptor activation, receptor specificity, and growth hormone secretagogue signaling dynamics. In preclinical research environments, Ipamorelin has been studied for its interaction with growth hormone secretagogue receptors, intracellular calcium mobilization, and downstream signaling cascades associated with ghrelin-mediated pathways. Its selective receptor profile makes it particularly valuable for mechanistic investigations requiring focused pathway analysis and minimal off-target receptor interaction. Scientific interest in Ipamorelin continues to expand due to its receptor selectivity and utility in studies involving endocrine signaling and peptide-receptor communication. Researchers frequently utilize this compound to investigate receptor activation behavior, intracellular signaling mechanisms, and the integration of ghrelin-associated pathways within controlled laboratory models. Current areas of scientific investigation include ghrelin receptor binding and selectivity studies, growth hormone secretagogue signaling analysis, intracellular calcium mobilization research, endocrine signaling pathway investigation, receptor activation kinetics studies, and peptide signaling network analysis.
Key Highlights
Product Name: Ipamorelin
Strength:10MG
Chemical Name: Growth Hormone Secretagogue Peptide (Selective Ghrelin Receptor Agonist)
CAS Number: 170851-70-4
Molecular Formula: C₃₈H₄₉N₉O₅
Molecular Weight: 711.85 g/mol
Amino Acid Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
Appearance: White to Off-White Lyophilized Powder
Classification: Peptide Hormone Analogue Research Compound
Purity: Verified by analytical testing prior to release
Analytical Methods: HPLC, Mass Spectrometry (MS)
Research Applications
Research areas commonly associated with this compound include:
Growth Hormone
Recovery & Performance
Storage & Handling
Store lyophilized material refrigerated at 2–8°C for routine storage. For optimal long-term preservation, materials may be stored frozen. Once reconstituted, maintain at 2–8°C and protect from excessive heat, moisture, and direct light. Avoid repeated freeze-thaw cycles and keep materials in their original sealed container until ready for use. Proper storage and handling practices help preserve product integrity, stability, and overall quality.
By purchasing from BioRogue Peptides, the purchaser acknowledges that all products are being acquired solely for lawful research purposes and will be handled in accordance with applicable regulations and accepted laboratory practices.
The purchaser assumes responsibility for the proper handling, storage, and use of all materials. BioRogue Peptides makes no representations, warranties, or claims regarding any application beyond legitimate research use.
HEALTH CANADA WARNING
Unauthorized health products have not been approved by Health Canada, which means that they have not been assessed for safety, efficacy and quality and may pose a range of serious health risks. They may contain high-risk ingredients, such as prescription or controlled drugs, and additives or contaminants that may or may not be listed on the label. The level of active ingredients could be higher or lower than claimed and these ingredients could interact with other medications and foods. Prescription drugs should only be used under the care of a licensed health care professional because they are intended to treat specific conditions and may cause serious side effects. Prescription drugs can only be legally sold to consumers in Canada with a prescription.
